The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

Overview of attention for article published in Journal of Hematology & Oncology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 17 X posts from 17 X users, with an upper bound of 11,857 followers.

RT @smbenlazar: The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades https://t.co/SXVfDQup5n…

RT @smbenlazar: The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades https://t.co/SXVfDQup5n…

RT @smbenlazar: The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades https://t.co/SXVfDQup5n…

RT @smbenlazar: The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades https://t.co/SXVfDQup5n…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.